title: MiR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors.
abstract: A recurring challenge for brain pathologists is to diagnose whether a brain malignancy is a primary tumor or a metastasis from some other tissue. The accurate diagnosis of brain malignancies is essential for selection of proper treatment. MicroRNAs are a class of small non-coding RNA species that regulate gene expression; many exhibit tissue-specific expression and are misregulated in cancer. Using microRNA expression profiling, we found that hsa-miR-92b and hsa-miR-9/hsa-miR-9* are over-expressed, specifically in brain primary tumors, as compared to primary tumors from other tissues and their metastases to the brain. By considering the expression of only these two microRNAs, it is possible to distinguish between primary and metastatic brain tumors with very high accuracy. These microRNAs thus represent excellent biomarkers for brain primary tumors. Previous reports have found that hsa-miR-92b and hsa-miR-9/hsa-miR-9* are expressed more strongly in developing neurons and brain than in adult brain. Thus, their specific over-expression in brain primary tumors supports a functional role for these microRNAs or a link between neuronal stem cells and brain tumorigenesis.
authors.affiliation: Department of Pathology, Sheba Medical Center, Tel-Hashomer, Israel.
authors.forename: Dvora
authors.initials: D
authors.lastname: Nass
authors.forename: Shai
authors.initials: S
authors.lastname: Rosenwald
authors.forename: Eti
authors.initials: E
authors.lastname: Meiri
authors.forename: Shlomit
authors.initials: S
authors.lastname: Gilad
authors.forename: Hilla
authors.initials: H
authors.lastname: Tabibian-Keissar
authors.forename: Anat
authors.initials: A
authors.lastname: Schlosberg
authors.forename: Hagit
authors.initials: H
authors.lastname: Kuker
authors.forename: Netta
authors.initials: N
authors.lastname: Sion-Vardy
authors.forename: Ana
authors.initials: A
authors.lastname: Tobar
authors.forename: Oleg
authors.initials: O
authors.lastname: Kharenko
authors.forename: Einat
authors.initials: E
authors.lastname: Sitbon
authors.forename: Gila
authors.initials: G
authors.lastname: Lithwick Yanai
authors.forename: Eran
authors.initials: E
authors.lastname: Elyakim
authors.forename: Hila
authors.initials: H
authors.lastname: Cholakh
authors.forename: Hadas
authors.initials: H
authors.lastname: Gibori
authors.forename: Yael
authors.initials: Y
authors.lastname: Spector
authors.forename: Zvi
authors.initials: Z
authors.lastname: Bentwich
authors.forename: Iris
authors.initials: I
authors.lastname: Barshack
authors.forename: Nitzan
authors.initials: N
authors.lastname: Rosenfeld
mesh_terms: D000328:Adult; D019540:Area Under Curve; D014408:Biomarkers, Tumor / Q000235:genetics*; D001932:Brain Neoplasms / Q000175:diagnosis* / Q000235:genetics*; D003937:Diagnosis, Differential; D015870:Gene Expression; D006801:Humans; D035683:MicroRNAs / Q000235:genetics*; D009362:Neoplasm Metastasis / Q000175:diagnosis*; D020411:Oligonucleotide Array Sequence Analysis; D012372:ROC Curve; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012680:Sensitivity and Specificity
chemical_list: D014408:Biomarkers, Tumor; D035683:MicroRNAs